Related Experiment Video
Updated: Dec 29, 2025

Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells
Published on: September 25, 2019
New Bicistronic TALENs Greatly Improve Genome Editing
José María Martín-Fernández1, Aarne Fleischer1,2, Sara Vallejo-Diez2
1Karuna Good Cells Technologies SL, Vitoria-Gasteiz, Álava, Spain.
Researchers developed a more efficient transcription activator-like effector nuclease (TALEN) system for gene editing. This novel TALEN approach streamlines cell selection, accelerating stem cell and regenerative medicine research.
Area of Science:
- Molecular Biology
- Gene Editing Technologies
Background:
- Genome editing is crucial in stem cell and regenerative medicine.
- Current methods using transcription activator-like effector nucleases (TALENs) require improvement for efficiency.
Purpose of the Study:
- To introduce a novel, highly efficient TALEN system for gene editing.
- To improve the selection process for successfully edited cells.
Main Methods:
- Generation of bicistronic TALEN genes linked to reporter molecules (TALEN-F, TALEN-M).
- Utilizing fluorescence-assisted cell sorting (FACS) or magnetic-activated cell sorting (MACS) for reporter-based selection.
- Application in primary T cell editing.
Main Results:
- The bicistronic TALEN system enables rapid enrichment of cells with active TALEN pairs.
- Eliminates the need for extensive culture selection and clone characterization.
- Demonstrates successful editing of primary T cells.
Conclusions:
- The new TALEN system significantly enhances gene editing efficiency and cell selection.
- This advancement accelerates research in stem cell and regenerative medicine.
- Facilitates faster generation and characterization of edited cell populations.
More Related Videos
09:51Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
Published on: February 2, 2016
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Related Concept Videos
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Homologous Recombination
CRISPR/Cas9 Genome Editing
CRISPR